MyMD Pharmaceuticals, Inc. Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 97.01. In total, the insiders bought 17 593 309 and sold 532 775 MYMD shares in the last 100 trades.

Insider Power

(Last 100 transactions)
97.01
Buy 17 593 309 Shares
Sell 532 775 Shares

Historical Insider Trades

Date Type Action Person Amount
Jun 13, 2024 Buy Friscia Stephen 0
May 23, 2024 Series G Convertible Preferred Stock Buy Pharmacyte Biotech, Inc. 3 854 626
May 23, 2024 Warrants Buy Pharmacyte Biotech, Inc. 3 854 626
Apr 08, 2024 Buy Glass Mitchell 0
Aug 24, 2023 Common stock Buy Rivard Paul 150 000
Aug 17, 2023 Common stock Buy Rivard Paul 25 000
Jun 07, 2023 Employee Stock Option (Right to Buy) Buy Chapman Christopher C Jr 300 000
Jun 07, 2023 Employee Stock Option (Right to Buy) Buy Kaplin Adam 150 000
Jun 07, 2023 Employee Stock Option (Right to Buy) Buy Uzonwanne Jude 150 000
Jun 07, 2023 Employee Stock Option (Right to Buy) Buy Schreiber Christopher C 150 000
Jun 07, 2023 Employee Stock Option (Right to Buy) Buy Eagle Craig 475 000
Jun 07, 2023 Employee Stock Option (Right to Buy) Buy Silverman Joshua 200 000
Jun 07, 2023 Employee Stock Option (Right to Buy) Buy White Billy Joe 150 000
Jun 07, 2023 Employee Stock Option (Right to Buy) Buy Rivard Paul 150 000
Apr 04, 2023 Employee Stock Option (Right to Buy) Buy Chapman Christopher C Jr 750 000
Dec 08, 2022 Common stock Buy Rivard Paul 10 000
Nov 26, 2021 Common Stock Buy Silverman Joshua 5 000
Nov 24, 2021 Common Stock Buy Silverman Joshua 3 266
Nov 24, 2021 Common Stock Buy Silverman Joshua 6 734
Nov 23, 2021 Common stock Buy Rivard Paul 15 000
Oct 14, 2021 Restricted Stock Units Buy Kaplin Adam 600 000
Oct 14, 2021 Restricted Stock Units Buy Schreiber Christopher C 150 000
Oct 14, 2021 Restricted Stock Units Buy White Billy Joe 150 000
Oct 14, 2021 Restricted Stock Units Buy Uzonwanne Jude 150 000
Oct 14, 2021 Restricted Stock Units Buy Eagle Craig 150 000
Click to get the best stock tips daily for free!

About MyMD Pharmaceuticals, Inc.

MyMD Pharmaceuticals. MyMD Pharmaceuticals, Inc., a clinical development stage pharmaceutical company, focuses on developing various therapeutic platforms to treat the causes of disease. The company is developing MYMD-1, a drug platform based on a clinical stage small molecule that regulates the immune system to control TNF-a, which drives chronic inflammation, and other pro-inflammatory cell signaling cytokines; and to delay aging and increase longevity, as well as t... MYMD Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT